These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8681641)

  • 21. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
    Dheda K; Shean K; Zumla A; Badri M; Streicher EM; Page-Shipp L; Willcox P; John MA; Reubenson G; Govindasamy D; Wong M; Padanilam X; Dziwiecki A; van Helden PD; Siwendu S; Jarand J; Menezes CN; Burns A; Victor T; Warren R; Grobusch MP; van der Walt M; Kvasnovsky C
    Lancet; 2010 May; 375(9728):1798-807. PubMed ID: 20488525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis.
    Lee SS; Lee CM; Kim TH; Kim JJ; Lee JM; Kim HJ; Ha CY; Kim HJ; Jung WT; Lee OJ; Kim DY
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):800-5. PubMed ID: 27155184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of multidrug-resistant tuberculosis: definition of the outcome 'failure'.
    Chiang CY; Van Deun A; Trébucq A; Heldal E; Caminero JA; Aït-Khaled N
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):4-5. PubMed ID: 21276289
    [No Abstract]   [Full Text] [Related]  

  • 24. Tooth Discoloration in a Patient With Multidrug-Resistant Tuberculosis.
    Clin Infect Dis; 2016 Mar; 62(5):617; 664-5. PubMed ID: 26908847
    [No Abstract]   [Full Text] [Related]  

  • 25. Bedaquiline. More data needed on this dangerous antitubercular drug.
    Prescrire Int; 2014 Oct; 23(153):232-4. PubMed ID: 25964964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
    Achar J; Hewison C; Cavalheiro AP; Skrahina A; Cajazeiro J; Nargiza P; Herboczek K; Rajabov AS; Hughes J; Ferlazzo G; Seddon JA; du Cros P
    Emerg Infect Dis; 2017 Oct; 23(10):1711-3. PubMed ID: 28758889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis drug resistance and HIV infection, the Netherlands.
    Haar CH; Cobelens FG; Kalisvaart NA; van der Have JJ; van Gerven PJ; van Soolingen D
    Emerg Infect Dis; 2007 May; 13(5):776-8. PubMed ID: 17553264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding the evidence base supporting shorter treatment durations for multidrug-resistant tuberculosis.
    Nuermberger E; Yew WW
    Int J Tuberc Lung Dis; 2015 May; 19(5):497-8. PubMed ID: 25868013
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran.
    Bialvaei AZ; Kafil HS; Asgharzadeh M
    Clin Infect Dis; 2015 Sep; 61(6):1029-30. PubMed ID: 26060290
    [No Abstract]   [Full Text] [Related]  

  • 30. Multidrug-resistant tuberculosis: treatment is empirical, for want of robust trials.
    Prescrire Int; 2014 Oct; 23(153):245-6. PubMed ID: 25964976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced hypothyroidism in patients receiving treatment for multidrug-resistant tuberculosis in the UK.
    Gupta J; Breen RA; Milburn HJ
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1278. PubMed ID: 22871328
    [No Abstract]   [Full Text] [Related]  

  • 32. Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.
    Kendall EA; Fojo AT; Dowdy DW
    Lancet Respir Med; 2017 Mar; 5(3):191-199. PubMed ID: 27989591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa.
    Khan M; Pillay T; Moodley J; Ramjee A; Padayatchi N
    Int J Tuberc Lung Dis; 2007 Jun; 11(6):706-8. PubMed ID: 17519106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When students become patients: TB disease among medical undergraduates in Cape Town, South Africa.
    Van der Westhuizen HM; Dramowski A
    S Afr Med J; 2017 May; 107(6):475-479. PubMed ID: 28604316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
    Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
    Muñoz-Torrico M; Caminero-Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Vergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Arch Bronconeumol; 2017 May; 53(5):245-250. PubMed ID: 28089216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From the Centers for Disease Control and Prevention. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
    JAMA; 2001 May 23-30; 285(20):2572-3. PubMed ID: 11396466
    [No Abstract]   [Full Text] [Related]  

  • 38. Moxifloxacin induced encephalopathy in disseminated tuberculosis: A case report.
    Mittal GK; Reddy VASK; Akhtar SM; Kaur H
    Indian J Tuberc; 2020 Jul; 67(3):423-425. PubMed ID: 32825886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistant TB is less transmissible than drug susceptible strains, study shows.
    Mayor S
    BMJ; 2015 Jun; 350():h3367. PubMed ID: 26109493
    [No Abstract]   [Full Text] [Related]  

  • 40. A patient of multidrug-resistant tuberculosis on category IV treatment regimen presenting with psychosis.
    Sarkar S; Sood M
    Natl Med J India; 2011; 24(4):244-5. PubMed ID: 22208150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.